8Suppliers
2Customers
1Debt Items
20Related Chains

Alvotech Suppliers

TickerNameConfidenceEvidence
CONTRACT-MANUFACTURING-ORGANIZATIONS CONTRACT-MANUFACTURING-ORGANIZATIONS 90% We partly rely on third-party manufacturers (contract manufacturing organizations, or “CMOs”) to manufacture and supply our product candidates for our preclinical and clinical studies
THIRD-PARTY-CONTRACTORS THIRD-PARTY-CONTRACTORS 80% we rely on third parties to manufacture nonclinical and clinical supplies of our product candidates, to store critical components of our product candidates and perform various services related to the…
THIRD-PARTY-MANUFACTURING-VENDORS THIRD-PARTY-MANUFACTURING-VENDORS 80% one or more of our third-party manufacturing vendors may be found on regulatory inspection by the FDA or other comparable foreign regulatory authorities to be noncompliant with cGMP regulations
KMDA Kamada Ltd. 72% Reciprocal relationship from KMDA graph: License Application (BLA) of the product, in consideration for a $ million payment from Takeda, which was paid by Takeda and accounted for as income during th…
LENZ LENZ Therapeutics, Inc. 72% Reciprocal relationship from LENZ graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from LENZ graph: Reciprocal relationship from ALVO graph: Reciprocal relationship from LENZ g…
COLLABORATION-PARTNERS COLLABORATION-PARTNERS 70% our collaboration partners and contract manufacturers are subject to significant regulation with respect to manufacturing our product candidates
CONTRACT-MANUFACTURING-PARTNERS CONTRACT-MANUFACTURING-PARTNERS 70% Although we oversee our contract manufacturers, we cannot control the implementation of the manufacturing process by the contract manufacturing partners
THIRD-PARTY-VENDORS THIRD-PARTY-VENDORS 60% we cannot be certain that identifying and establishing relationships for these services would not result in significant delay or increased cost in the development of our product candidates or manufac…

Alvotech Customers

TickerNameConfidenceEvidence
KMDA Kamada Ltd. 72% Reciprocal relationship from KMDA graph: ch were received and accounted for as income through December 31, 2021, and for a minimum commitment of Takeda to acquire GLASSIA produced by the Company over…
LENZ LENZ Therapeutics, Inc. 72% Reciprocal relationship from LENZ graph: Item 1. Business Overview We are a commercial pharmaceutical company focused on the development and commercialization of innovative therapies to improve visio…

Alvotech Debt Obligations

InstrumentDescriptionConfidenceEvidence
ALVO-DEBT Debt stack $1.5B 90% Market cache reports total debt of $1.5B.

Alvotech Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Alvotech.

Alvotech Ownership

HolderNameConfidenceEvidence
ALVO-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 57 tracked holders.

Alvotech Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
NBP NovaBridge Biosciences 100.00 2
TEVJF Teva Pharmaceutical Industries Limited 100.00 1 ['spend']
ITGR Integer Holdings Corporation 100.00 2
IINN Inspira Technologies Oxy B.H.N. Ltd. 100.00 2
AORT Artivion, Inc. 100.00 2
NVS Novartis AG 100.00 2
EXAS Exact Sciences Corp 100.00 2
GIFOF Grifols, S.A. 100.00 2
GIFLF Grifols, S.A. 100.00 2
LENZ LENZ Therapeutics, Inc. 100.00 1 ['customer', 'supplier']
VTAK Catheter Precision, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
GRFS Grifols, S.A. 100.00 2
GCTK GlucoTrack, Inc. 100.00 2
FLGT Fulgent Genetics, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
GIKLY Grifols, S.A. 100.00 2
GRAL GRAIL, Inc. 100.00 2
IVA Inventiva S.A. 100.00 2
SNYNF Sanofi 100.00 2